Testosterone Replacement for Male Opioid Agonist Maintained Patients

Completed · Phase 1/Phase 2

Conditions studied: Chronic Pain, Opioid Addiction, Symptomatic Hypogonadism

In brief

This study is designed to develop an effective treatment intervention for chronic pain, symptomatic hypogonadism, and opioid addiction

Key facts

Study ID

NCT01873989

Run by

Yale University

People needed

15

Starts

2012-04-01

Expected to finish

2015-01-01

Last updated by the study team

2017-06-12

Who can join

Age: 18 and older, up to 50. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Between 18 and 50 years of age
• Male buprenorphine- or methadone-maintained patients at the APT Foundation
• Moderate to severe chronic pain
• Meet criteria for symptomatic hypogonadism
• Understand English
• Interested in receiving testosterone replacement

You may not qualify if…

• Current suicide or homicide risk
• Life-threatening or unstable medical condition
• Known or suspected prostate or chest cancer or history of polycythemia

Where it is running

• MRU, APT Foundation, Inc — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.